SKB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
SKB BIO-B: INSIDE INFORMATIONPROPOSED IMPLEMENTATION OFTHE H SHARE FULL CIRCULATION BY THE COMPANY
SKB BIO-B: ARTICLES OF ASSOCIATION
SKB BIO-B: List of Directors and their Roles and Functions
SKB BIO-B: VOLUNTARY ANNOUNCEMENTINVESTIGATIONAL NEW DRUG APPROVAL FOR INNOVATIVE DRUGSKB518 FOR INJECTION BY THE NATIONAL MEDICAL PRODUCTSADMINISTRATION
SKB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
SKB BIO-B: REVISED FORM OF PROXY FOR THE 2023 ANNUAL GENERAL MEETINGTO BE HELD ON JUNE 20, 2024
SKB BIO-B: List of Directors and their Roles and Functions
SKB BIO-B: VOLUNTARY ANNOUNCEMENTSTUDY RESULTS FOR CORE PRODUCT SACITUZUMAB TIRUMOTECAN(SAC-TMT) AT 2024 ASCO ANNUAL MEETING
SKB BIO-B: FORM OF PROXY FOR THE 2023 ANNUAL GENERAL MEETINGTO BE HELD ON JUNE 20, 2024
SKB BIO-B: Next Day Disclosure Return
SKB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
SKB BIO-B: VOLUNTARY ANNOUNCEMENTKEY PRODUCT A400 (EP0031) CLEARED TO START PHASE 2BY THE US FOOD AND DRUG ADMINISTRATION
SKB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
SKB BIO-B: VOLUNTARY ANNOUNCEMENTSTUDY RESULTS FOR CORE PRODUCT SACITUZUMABTIRUMOTECAN (SAC-TMT) AT AACR ANNUAL MEETING 2024
SKB BIO-B: VOLUNTARY ANNOUNCEMENT CORE PRODUCT SKB264 (MK-2870) GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR FIRST-LINE TREATMENT OF UNRESECTABLE LOCALLY ADVANCED, RECURRING OR METASTATIC PD-L1 NEGATIVE TNBC BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
SKB BIO-B: VOLUNTARY ANNOUNCEMENT KEY PRODUCT A400 (EP0031) GRANTED FAST TRACK DESIGNATION BY THE US FOOD AND DRUG ADMINISTRATION
SKB BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
SKB BIO-B: VOLUNTARY ANNOUNCEMENTINCLUSION IN STOCK LIST OFSTOCK CONNECT SOUTHBOUND TRADING LINK
SKB BIO-B: VOLUNTARY ANNOUNCEMENTUPDATE ON COLLABORATION WITH MERCK SHARP & DOHME LLCFOR CORE PRODUCT SKB264 (MK-2870)
No Data